How Long Does Mounjaro Take to Get Out of Your System?

Step 1 — Understanding the half-life (days 1–5 after your last dose)

Every medicine has a half-life: the time it takes for the concentration in your bloodstream to fall by half. For tirzepatide, that figure is approximately five days, as detailed in the NHS medicines information for tirzepatide. So on day five after your final injection, roughly half the drug remains circulating. On day ten, roughly a quarter. The body is not quite done yet.

This slow exit is by design. Tirzepatide is engineered with a fatty-acid chain that binds it to albumin in the blood, extending its action long enough for once-weekly dosing to work. The same property that makes one injection last seven days also means the medicine lingers well beyond the week you stopped using it.

Practically, this means the appetite-suppressing effects and any side effects do not switch off the day you skip a pen. Many people notice hunger returning gradually, not all at once, over the first couple of weeks. If you are curious about how the drug builds up during the loading phase, the same pharmacokinetics apply in reverse on the way out.

Step 2 (The washout window (weeks 1–5)

Pharmacokinetics convention treats five half-lives as the point at which a drug is effectively cleared) below 3–5% of its original concentration. For tirzepatide, five half-lives lands at around 25 days, or just under four weeks. If you want a detailed breakdown of the full clearance timeline, our page covering how long Mounjaro stays out of your system walks through the pharmacokinetics day by day. Clinical guidance generally rounds this to approximately five weeks to account for individual variation in how quickly different people metabolise the medicine.

Several things change during this window. Gastric emptying, which tirzepatide slows considerably, returns toward its baseline rate as drug levels fall. That matters most for anyone scheduled for surgery: NHS England's guidance on weight-management injections advises patients to tell their anaesthetist they are taking a GLP-1 or dual-agonist medicine before any procedure, precisely because residual gastric slowing can increase aspiration risk even after a standard nil-by-mouth period. If you are planning an elective procedure and wondering whether to pause treatment first, discuss the timing with both your surgeon and your prescriber.

Contraception is another consideration during this period. Women using oral contraceptives should add a non-oral method for the first four weeks of Mounjaro treatment and for four weeks after each dose increase, because the medicine's effect on absorption may reduce pill effectiveness. The same logic applies in reverse: if you are stopping Mounjaro and returning to oral contraception only, a conversation with your prescriber or GP about timing is sensible.

Step 3 (What changes after clearance, and what to expect

Once tirzepatide has cleared, the physiological effects that supported weight loss) reduced appetite, slower gastric emptying, improved insulin sensitivity — no longer have pharmacological backing. Research published in major clinical journals consistently shows that weight regain begins for many people within weeks of stopping GLP-1 and dual-agonist treatment, though the rate varies considerably between individuals.

This is not a failure of willpower. The biology that drove the original weight gain reasserts itself once the medicine is gone. For people who have achieved a meaningful reduction and want to maintain it, this is worth planning for well before the last pen. Understanding how long the medicine takes to produce results gives useful context here: the benefits built gradually, and they can also unwind gradually.

Diet, protein intake, strength-based activity and behavioural habits built during treatment are the most practical tools for bridging the gap. The NHS England guidance on weight-management injections emphasises exactly this kind of wraparound support. A prescriber who has followed your treatment from the start is best placed to help you plan what comes next, whether that means continuing, pausing with a plan, or transitioning to a different approach. You can find out more about the full Mounjaro treatment overview, or explore your options on the weight-loss treatments page.

One practical note: some people restart Mounjaro after a break. If that applies to you, most clinical protocols require restarting at the 2.5mg dose to allow your system to readjust, regardless of where you stopped. Your prescriber will advise on the specifics. You can also read more about the clearance timeline if you want the pharmacokinetic detail before that conversation.

If you have questions about whether Mounjaro is right for you, or are thinking about starting treatment, check your eligibility with our prescribers. A clinician reads every consultation the same day, not a bot.